Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress formation of breast cancers. A new study indicates that it binds to another protein in an inflammatory cell pathway, ...
Dec 8, 2022
0
2
Patients with cancer who were living with human immunodeficiency virus (HIV) infection had increased epigenetic age—a type of biological age defined by DNA methylation patterns—compared with patients with cancer without ...
Nov 18, 2022
0
3
When your body fights off an infection, you develop a fever. If you have arthritis, your joints will hurt. If a bee stings your hand, your hand will swell up and become stiff. These are all manifestations of inflammation ...
Nov 7, 2022
0
2
Hemophilia A is the most common severe form of hemophilia. It almost exclusively affects males. The disease can usually be treated well, but not for all sufferers. A study at the University of Bonn has now elucidated an important ...
Oct 26, 2022
0
25
In the search for effective and safe therapeutics for hyposensitization, colleagues at the Paul-Ehrlich-Institut and the Justus Liebig University in Giessen investigated the effect of the birch pollen allergen-containing ...
Oct 10, 2022
0
51
Type 1 diabetes (T1D) is an autoimmune disease in which the pancreas makes little or no insulin. The details on the events that occur during autoimmune destruction of the pancreatic beta-cells have been studied extensively ...
Sep 23, 2022
0
226
Together with researchers from University Hospital Mainz, the University of Regensburg and the IRCM in Montreal (Canada), a research team from Friedrich Schiller University Jena has discovered a novel therapeutic approach ...
Sep 21, 2022
0
4
When real patients have unprecedented positive outcomes to a new treatment, it's tempting to talk about it as "breakthrough" for medical science. This describes the excitement around a new report from researchers in Germany ...
Sep 19, 2022
0
8
An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found.
Aug 26, 2022
0
41
A new immunological treatment against hepatitis B and D viruses, both of which can cause liver cancer, shows promising results in animal models. Results from the treatment, which is being developed by researchers at Karolinska ...
Aug 26, 2022
0
43
